Severe immune thrombocytopenic purpura in critical COVID-19

Springer Science and Business Media LLC - Tập 112 Số 5 - Trang 746-750 - 2020
Valérie Levesque1, Émilie Millaire1, Daniel Corsilli2, Benjamin Rioux-Massé3, François Martin Carrier3
1Department of Medicine, Université de Montréal, Montréal, Canada
2Department of Medicine - Critical Care Division, Centre hospitalier de I'Université de Montréal, Montréal, Canada
3Department of Medicine - Hematology Division, Centre hospitalier de I'Université de Montréal, Montréal, Canada

Tóm tắt

Từ khóa


Tài liệu tham khảo

Guan W-J, Ni Z-Y, Hu Y, Liang W-H, Ou C-Q, He J-X, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–20.

Yang M, Ng MHL, Li CK. Thrombocytopenia in patients with severe acute respiratory syndrome. Hematology. 2005;10(2):101–5.

Liebman HA. Viral-associated immune thrombocytopenic purpura. Hematol Am Soc Hematol Educ Program. 2008;1:212–8.

Neunert C, Terrell DR, Arnold DM, Buchanan G, Cines DB, Cooper N, et al. American society of hematology 2019 guidelines for immune thrombocytopenia. Blood Adv. 2019;3(23):3829–66.

Zulficar AA, Lorenzo-Villalba N, Hassler P, Andrès E. Immune throbocytopenic purpura in a patient with COVID-19. N Engl J Med. 2020;383(18):e43.

Bomhof G, Mutsaers PGNJ, Leebeek FWG, Boekhorstte PAW, Hofland J, Croles FN, et al. COVID-19-associated immune thrombocytopenia. Br J Haematol. 2020. (published online 2020 May 18).

Arnold DM, Kukaswadia S, Nazi I, Esmail A, Dewar L, Smith JW, et al. A systematic evaluation of laboratory testing for drug-induced immune thrombocytopenia. J Thromb Haemost. 2013;11(1):169–76.

Helms J, Tacquard C, Severac F, Leonard-Lorant I, Ohana M, Delabranche X, et al. High risk of thrombosis in patients in severe SARS-CoV-2 infection: a multicentre prospective cohort study. Intensive Care Med. 2020;46(6):1089–1098.

Chen W, Li Z, Yang B, Wang P, Zhou Q, Zhang Z, et al. Delayed-phase thrombocytopenia in patients of coronavirus disease 2019 (COVID-19). Br J Haematol. 2020. (published online 2020 May 26).

Wang T, Liu Z, Wang Z, Duan M, Li G, Want S, et al. Thrombocytopenia is associated with acute respiratory distress syndrome mortality: an international study. PLoS One. 2014;9(4):e94124.

Samson M, Fraser W, Lebowitz D. Treatments for primary immune thrombocytopenia: a review. Cureus. 2019;11(10):e5849.

Neunert C, Noroozi N, Norman G, Buchanan GR, Goy J, Nazi I, et al. Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic review. J Thromb Haemost. 2015;13(3):457–64.

Pavord S, Thachil J, Hunt B, Murphy M, Lowe G, Laffan M, et al. Practical guidance for the management of adults with Immune Thrombocytopenia during the COVID-19 pandemic. Br J Haematol. 2020;189(6):1038–1043.